Publications found:
60,074
Sort by:
2018 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 9,800.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the US cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
620 pages
2018 France Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in France ...
June 2018
585 pages
2018 Germany Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Germany ...
June 2018
585 pages
2018 Japan Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 8,800.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Japan ...
June 2018
590 pages
2018 Spain Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, ... market dynamics, structure, size, growth and major suppliers. Estimated universe of laboratories performing cancer diagnostic testing. Cancer statistics, etiology and recent developments in Spain ...
June 2018
565 pages
2018 UK Cancer Diagnostics Market Segmentation Analysis: Hospitals, Commercial Labs--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 6,700.00
... ; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the researchers approach ... of the disease. During the next five years, the UK cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field ...
June 2018
565 pages
2018 Europe Cancer Diagnostics Market Segmentation Analysis: France, Germany, Italy, Spain, UK--Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains
US$ 19,700.00
... identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the verge of explosion, as the ... universe of laboratories performing cancer diagnostic testing by country. Cancer statistics, etiology and recent developments in Europe. Business Opportunities and Strategic ...
June 2018
820 pages
Immunodiagnostics: Spot Fast-Growing Market Segments--Therapeutic Drug Monitoring, Endocrine Function, Tumor Markers, Special Chemistry, Immunoproteins, Drugs of Abuse
US$ 24,500.00
... Triglycerides, Troponin, Uric Acid. Therapeutic Drug Monitoring (TDM) Amikacin, ... marketing tactics, and new products in R&D. Market Segmentation Analysis Comprehensive market segmentation analysis, including review of the market ... emerging clinical chemistry and immunodiagnostic tests. Review of current ...
June 2018
1115 pages
Zimmer: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Zimmer, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
Aesculap: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Aesculap, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
22 pages
Biomet: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Biomet, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Wright Medical: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Wright Medical, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages
ConMed: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of ConMed, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Medtronic: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Medtronic, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
25 pages
Smith & Nephew: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Smith & Nephew, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
37 pages
Stryker: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Stryker, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
35 pages
Synthes: Market Segment Forecasts and Company Strategic Assessment
US$ 1,850.00
A strategic assessment of Synthes, one of the world's leading orthopedics companies, provides significant competitor ... , analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company ...
June 2018
30 pages